These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19071461)

  • 41. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
    Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T; Maunu SL
    Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of carbamazepine polymorphic contents in double-layered tablets using transmittance- and reflectance-near-infrared spectroscopy involving chemometrics.
    Otsuka M; Fukui Y
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1404-12. PubMed ID: 20515394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets.
    Yamada H; Masuda K; Ishige T; Fujii K; Uekusa H; Miura K; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2011 Sep; 56(2):448-53. PubMed ID: 21703798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
    Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
    J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of trace crystallinity in an amorphous system using Raman microscopy and chemometric analysis.
    Widjaja E; Kanaujia P; Lau G; Ng WK; Garland M; Saal C; Hanefeld A; Fischbach M; Maio M; Tan RB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):45-54. PubMed ID: 20969956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of pulverization of the bulk powder on the hydration of creatine anhydrate tablets and their pharmaceutical properties.
    Sakata Y; Shiraishi S; Otsuka M
    Colloids Surf B Biointerfaces; 2005 Dec; 46(2):92-100. PubMed ID: 16274970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Viganò E; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2009 Dec; 50(5):764-70. PubMed ID: 19570642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applications of cathodoluminescence spectroscopy and imaging in the characterisation of pharmaceutical materials.
    Nichols G
    Eur J Pharm Sci; 2012 Jan; 45(1-2):19-42. PubMed ID: 22074938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlling individual steps in the production process of paracetamol tablets by use of NIR spectroscopy.
    Blanco M; Cueva-Mestanza R; Peguero A
    J Pharm Biomed Anal; 2010 Mar; 51(4):797-804. PubMed ID: 19880266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorph and isomer conversion of complexes based on CuI and PPh3 easily observed via luminescence.
    Maini L; Braga D; Mazzeo PP; Ventura B
    Dalton Trans; 2012 Jan; 41(2):531-9. PubMed ID: 22057366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of the relative amounts of three crystal forms of a benzimidazole drug in complex finished formulations by FT-Raman spectroscopy.
    De Spiegeleer B; Seghers D; Wieme R; Schaubroeck J; Verpoort F; Slegers G; Van Vooren L
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):275-80. PubMed ID: 16085143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy.
    Tian F; Zeitler JA; Strachan CJ; Saville DJ; Gordon KC; Rades T
    J Pharm Biomed Anal; 2006 Feb; 40(2):271-80. PubMed ID: 16146681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raman mapping of low-content active-ingredient pharmaceutical formulations. part II: statistically optimized sampling for detection of less than 1% of an active pharmaceutical ingredient.
    Sasić S; Whitlock M
    Appl Spectrosc; 2008 Aug; 62(8):916-21. PubMed ID: 18702866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substrate-Induced Phase of a Benzothiophene Derivative Detected by Mid-Infrared and Lattice Phonon Raman Spectroscopy.
    Schrode B; Jones AOF; Resel R; Bedoya N; Schennach R; Geerts YH; Ruzié C; Sferrazza M; Brillante A; Salzillo T; Venuti E
    Chemphyschem; 2018 Apr; 19(8):993-1000. PubMed ID: 29498172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A synergic approach of X-ray powder diffraction and Raman spectroscopy for crystal structure determination of 2,3-thienoimide capped oligothiophenes.
    Cappuccino C; Mazzeo PP; Salzillo T; Venuti E; Giunchi A; Della Valle RG; Brillante A; Bettini C; Melucci M; Maini L
    Phys Chem Chem Phys; 2018 Jan; 20(5):3630-3636. PubMed ID: 29340428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sample Preparation of Posaconazole Oral Suspensions for Identification of the Crystal Form of the Active Pharmaceutical Ingredient.
    Lykouras M; Fertaki S; Orkoula M; Kontoyannis C
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects.
    Malanovic N; Birarda G; Eder S; Gruber-Woelfler H; Reiter F; Juraic K; Hodzic A
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.